COSMIC_FUSION_ID	FIVE_PRIME_GENE_SYMBOL	THREE_PRIME_GENE_SYMBOL	primary_tissue	sub_tissue	histology	sub_histology	COSMIC_PHENOTYPE_ID	FUSION_SYNTAX	FIVE_PRIME_CHROMOSOME	FIVE_PRIME_STRAND	FIVE_PRIME_TRANSCRIPT_ID	FIVE_PRIME_LAST_OBSERVE_EXON	FIVE_PRIME_GENOME_START_FROM	FIVE_PRIME_GENOME_START_TO	FIVE_PRIME_GENOME_STOP_FROM	FIVE_PRIME_GENOME_STOP_TO	THREE_PRIME_CHROMOSOME	THREE_PRIME_STRAND	THREE_PRIME_TRANSCRIPT_ID	THREE_PRIME_FIRST_OBSERVE_EXON	THREE_PRIME_GENOME_START_FROM	THREE_PRIME_GENOME_START_TO	THREE_PRIME_GENOME_STOP_FROM	THREE_PRIME_GENOME_STOP_TO	FUSION_TYPE	PUBMED_PMID
COSF1000	PCM1	JAK2	blood-lymph	NS	haematopoietic neoplasm	chronic myeloid leukaemia	COSO27985057	ENST00000325083.8(PCM1):r.?::ENST00000381652.3(JAK2):r.?			ENST00000325083.8								ENST00000381652.3						Inferred Breakpoint	16091753
COSF1045	SSBP2	JAK2	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000320672.4(SSBP2):r.1_583::ENST00000381652.3(JAK2):r.1821_5285	5	-	ENST00000320672.4	5.0	80809447.0	80809447.0	81047072.0	81047072.0	9	+	ENST00000381652.3	11.0	5069022.0	5069022.0	5128183.0	5128183.0	Observed mRNA	18618714
COSF1051	SQSTM1	ALK	blood-lymph	lymph node	lymphoid neoplasm	diffuse large B cell lymphoma	COSO27604818	ENST00000389805.4(SQSTM1):r.1_932::ENST00000389048.3(ALK):r.4080_6220	5	+	ENST00000389805.4	5.0	179247759.0	179247759.0	179252226.0	179252226.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	21134980
COSF1056	VCL	ALK	kidney	NS	carcinoma	renal medullary carcinoma	COSO296417407	ENST00000211998.4(VCL):r.1_2528::ENST00000389048.3(ALK):r.4080_6220	10	+	ENST00000211998.4	16.0	75757872.0	75757872.0	75865111.0	75865111.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	21213368
COSF1066	ETV6	JAK2	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000396373.4(ETV6):r.1_737+8654::ENST00000381652.3(JAK2):r.2487_5285	12	+	ENST00000396373.4	4.0	11802788.0	11802788.0	12015149.0	12015149.0	9	+	ENST00000381652.3	16.0	5078306.0	5078306.0	5128183.0	5128183.0	Inferred Breakpoint	9326218
COSF1069	SEC31A	JAK2	blood-lymph	lymph node	lymphoid neoplasm	Hodgkin lymphoma	COSO276011279	ENST00000348405.4(SEC31A):r.1_2904::ENST00000381652.3(JAK2):r.2626_5285	4	-	ENST00000348405.4	20.0	83763293.0	83763293.0	83812289.0	83812289.0	9	+	ENST00000381652.3	17.0	5080229.0	5080229.0	5128183.0	5128183.0	Inferred Breakpoint	21325169
COSF1071	PAX5	JAK2	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000358127.4(PAX5):r.1_679::ENST00000381652.3(JAK2):r.2929_5285	9	-	ENST00000358127.4	5.0	37002645.0	37002645.0	37034103.0	37034103.0	9	+	ENST00000381652.3	19.0	5081725.0	5081725.0	5128183.0	5128183.0	Inferred Breakpoint	19020546
COSF1102	CRTC1	MAML2	breast	NS	other	hidradenoma	COSO32225533	ENST00000321949.8(CRTC1):r.1_152::ENST00000524717.1(MAML2):r.1799_7106	19	+	ENST00000321949.8	1.0	18794487.0	18794487.0	18794638.0	18794638.0	11	-	ENST00000524717.1	2.0	95709762.0	95709762.0	95826681.0	95826681.0	Inferred Breakpoint	19827123
COSF1115	SLC45A3	ELK4	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000367145.3(SLC45A3):r.1_66::ENST00000357992.4(ELK4):r.332_10239	1	-	ENST00000367145.3	1.0	205649522.0	205649522.0	205649587.0	205649587.0	1	-	ENST00000357992.4	2.0	205577071.0	205577071.0	205593019.0	205593019.0	Inferred Breakpoint	19293179
COSF1116	KLK2	ETV1	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000325321.3(KLK2):r.1_271::ENST00000430479.1(ETV1):r.1223_6740	19	+	ENST00000325321.3	1.0	51376505.0	51376505.0	51376775.0	51376775.0	7	-	ENST00000430479.1	9.0	13930853.0	13930853.0	13971374.0	13971374.0	Observed mRNA	21036922
COSF1119	SLC45A3	ETV1	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000367145.3(SLC45A3):r.1_66::ENST00000430479.1(ETV1):r.904_6740	1	-	ENST00000367145.3	1.0	205649522.0	205649522.0	205649587.0	205649587.0	7	-	ENST00000430479.1	7.0	13930853.0	13930853.0	13978871.0	13978871.0	Inferred Breakpoint	17671502
COSF1121	HNRNPA2B1	ETV1	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000356674.7(HNRNPA2B1):r.1_175::ENST00000430479.1(ETV1):r.714_6740	7	-	ENST00000356674.7	1.0	26240192.0	26240192.0	26240366.0	26240366.0	7	-	ENST00000430479.1	4.0	13930853.0	13930853.0	14027798.0	14027798.0	Observed mRNA	20693979
COSF1125	ACSL3	ETV1	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000357430.3(ACSL3):r.1_491::ENST00000430479.1(ETV1):r.1034_6740	2	+	ENST00000357430.3	3.0	223725652.0	223725652.0	223765498.0	223765498.0	7	-	ENST00000430479.1	8.0	13930853.0	13930853.0	13975521.0	13975521.0	Inferred Breakpoint	18594527
COSF1133	NDRG1	ERG	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000323851.7(NDRG1):r.1_221::ENST00000442448.1(ERG):r.312_5034	8	-	ENST00000323851.7	3.0	134292475.0	134292475.0	134309480.0	134309480.0	21	-	ENST00000442448.1	4.0	39751952.0	39751952.0	39817544.0	39817544.0	Inferred Breakpoint	19649210
COSF1137	SLC45A3	ERG	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000367145.3(SLC45A3):r.1_66::ENST00000442448.1(ERG):r.312_5034	1	-	ENST00000367145.3	1.0	205649522.0	205649522.0	205649587.0	205649587.0	21	-	ENST00000442448.1	4.0	39751952.0	39751952.0	39817544.0	39817544.0	Observed mRNA	19649210
COSF1139	GOPC	ROS1	ovary	NS	low malignant potential (borderline) tumour	serous	COSO28245232	ENST00000368498.2(GOPC):r.1_1334::ENST00000368508.3(ROS1):r.5841_7435	6	-	ENST00000368498.2	8.0	117888017.0	117888017.0	117923527.0	117923527.0	6	-	ENST00000368508.3	35.0	117609463.0	117609463.0	117642557.0	117642557.0	Observed mRNA	12661006
COSF1143	KLK2	ETV4	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000325321.3(KLK2):r.1_271+828::ENST00000319349.5(ETV4):r.502-6624_2429	19	+	ENST00000325321.3	1.0	51376505.0	51376505.0	51377603.0	51377603.0	17	-	ENST00000319349.5	5.0	41605212.0	41605212.0	41620471.0	41620471.0	Inferred Breakpoint	18451133
COSF1155	CANT1	ETV4	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000392446.5(CANT1):r.1_67::ENST00000319349.5(ETV4):r.518_2429	17	-	ENST00000392446.5	1.0	77005746.0	77005746.0	77005812.0	77005812.0	17	-	ENST00000319349.5	5.0	41605212.0	41605212.0	41613831.0	41613831.0	Observed mRNA	18451133
COSF1157	SLC45A3	ETV5	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000367145.3(SLC45A3):r.1_66::ENST00000306376.5(ETV5):r.898_4111	1	-	ENST00000367145.3	1.0	205649522.0	205649522.0	205649587.0	205649587.0	3	-	ENST00000306376.5	8.0	185764097.0	185764097.0	185783861.0	185783861.0	Observed mRNA	18172298
COSF1159	TMPRSS2	ETV5	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000332149.5(TMPRSS2):r.1_79::ENST00000306376.5(ETV5):r.174_4111	21	-	ENST00000332149.5	1.0	42880008.0	42880008.0	42880086.0	42880086.0	3	-	ENST00000306376.5	2.0	185764097.0	185764097.0	185823731.0	185823731.0	Observed mRNA	18172298
COSF1166	DDX5	ETV4	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000225792.5(DDX5):r.1_709::ENST00000319349.5(ETV4):r.502_2429	17	-	ENST00000225792.5	3.0	62500340.0	62500340.0	62502639.0	62502639.0	17	-	ENST00000319349.5	5.0	41605212.0	41605212.0	41613847.0	41613847.0	Observed mRNA	18794152
COSF1168	ZNF700	MAST1	breast	NS	carcinoma	ER-positive carcinoma	COSO283919543	ENST00000254321.5(ZNF700):r.1_206::ENST00000251472.4(MAST1):r.2358_4833	19	+	ENST00000254321.5	1.0	12035883.0	12035883.0	12036088.0	12036088.0	19	+	ENST00000251472.4	20.0	12978544.0	12978544.0	12985765.0	12985765.0	Inferred Breakpoint	22101766
COSF1170	TADA2A	MAST1	breast	NS	carcinoma	NS	COSO28394862	ENST00000394395.2(TADA2A):r.1_1319::ENST00000251472.4(MAST1):r.814_4833	17	+	ENST00000394395.2	15.0	35766965.0	35766965.0	35834734.0	35834734.0	19	+	ENST00000251472.4	8.0	12962748.0	12962748.0	12985765.0	12985765.0	Observed mRNA	22101766
COSF1172	NFIX	MAST1	breast	NS	carcinoma	HER-positive carcinoma	COSO283912932	ENST00000360105.4(NFIX):r.1_633::ENST00000251472.4(MAST1):r.2179_4833	19	+	ENST00000360105.4	2.0	13135394.0	13135394.0	13136366.0	13136366.0	19	+	ENST00000251472.4	19.0	12978288.0	12978288.0	12985765.0	12985765.0	Inferred Breakpoint	22101766
COSF1174	ARID1A	MAST2	breast	NS	carcinoma	basal (triple-negative) carcinoma	COSO283911696	ENST00000324856.7(ARID1A):r.1_1508::ENST00000361297.2(MAST2):r.461_5738	1	+	ENST00000324856.7	1.0	27022524.0	27022524.0	27024031.0	27024031.0	1	+	ENST00000361297.2	2.0	46290105.0	46290105.0	46501796.0	46501796.0	Observed mRNA	22101766
COSF1176	GPBP1L1	MAST2	breast	NS	carcinoma	NS	COSO28394862	ENST00000290795.3(GPBP1L1):r.1_125+836::ENST00000361297.2(MAST2):r.784_5738	1	-	ENST00000290795.3	1.0	46151248.0	46151248.0	46152208.0	46152208.0	1	+	ENST00000361297.2	5.0	46425058.0	46425058.0	46501796.0	46501796.0	Observed mRNA	22101766
COSF1178	NOTCH1	GABBR2	breast	NS	carcinoma	basal (triple-negative) carcinoma	COSO283911696	ENST00000277541.6(NOTCH1):r.1_5714::ENST00000259455.2(GABBR2):r.2354_5761	9	-	ENST00000277541.6	30.0	139396200.0	139396200.0	139440314.0	139440314.0	9	-	ENST00000259455.2	14.0	101050391.0	101050391.0	101073487.0	101073487.0	Inferred Breakpoint	22101766
COSF1180	EWSR1	NFATC2	bone	humerus	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO28165222	ENST00000397938.2(EWSR1):r.1_1293::ENST00000396009.3(NFATC2):r.1381_7437	22	+	ENST00000397938.2	8.0	29664007.0	29664007.0	29684775.0	29684775.0	20	-	ENST00000396009.3	3.0	50003494.0	50003494.0	50133494.0	50133494.0	Observed mRNA	19318479
COSF1204	SEC16A	NOTCH1	breast	NS	carcinoma	basal (triple-negative) carcinoma	COSO283911696	ENST00000313050.7(SEC16A):r.1_118::ENST00000277541.6(NOTCH1):r.5095_9371	9	-	ENST00000313050.7	1.0	139372024.0	139372024.0	139372141.0	139372141.0	9	-	ENST00000277541.6	27.0	139388896.0	139388896.0	139397782.0	139397782.0	Observed mRNA	22101766
COSF1208	EWSR1	SMARCA5	bone	extraskeletal	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO52145222	ENST00000397938.2(EWSR1):r.1_1112::ENST00000283131.3(SMARCA5):r.983_7923	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	4	+	ENST00000283131.3	5.0	144446604.0	144446604.0	144478639.0	144478639.0	Observed mRNA	21113140
COSF1211	HEY1	NCOA2	bone	NS	chondrosarcoma	mesenchymal	COSO280610457	ENST00000354724.3(HEY1):r.1_531::ENST00000452400.2(NCOA2):r.2788_8447	8	-	ENST00000354724.3	4.0	80678886.0	80678886.0	80680098.0	80680098.0	8	-	ENST00000452400.2	13.0	71021997.0	71021997.0	71057083.0	71057083.0	Inferred Breakpoint	22034177
COSF1281	EWSR1	FLI1	bone	NS	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO28065222	ENST00000397938.2(EWSR1):r.1_1112::ENST00000527786.2(FLI1):r.1079_1144::ENST00000527786.2(FLI1):r.1211_4127	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	11	+	ENST00000527786.2	5.0	128651853.0	128651853.0	128651918.0	128651918.0	Observed mRNA	22508822
COSF1298	UBE2L3	KRAS	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000342192.4(UBE2L3):r.1_508::ENST00000311936.3(KRAS):r.182_5765	22	+	ENST00000342192.4	3.0	21921836.0	21921836.0	21965332.0	21965332.0	12	-	ENST00000311936.3	2.0	25357723.0	25357723.0	25398329.0	25398329.0	Inferred Breakpoint	22140652
COSF1304	EWSR1	FEV	bone	extraskeletal	Ewing sarcoma-peripheral primitive neuroectodermal tumour	adamantinoma-like	COSO521411029	ENST00000397938.2(EWSR1):r.?::ENST00000295727.1(FEV):r.?			ENST00000397938.2								ENST00000295727.1						Inferred Breakpoint	21181413
COSF1344	EWSR1	PBX1	bone	ilium	other	myoepithelial tumour	COSO572818144	ENST00000397938.2(EWSR1):r.?::ENST00000420696.2(PBX1):r.?			ENST00000397938.2								ENST00000420696.2						Inferred Breakpoint	20815032
COSF135	TMPRSS2	ERG	prostate	NS	carcinoma	NS	COSO32054862	ENST00000332149.5(TMPRSS2):r.1_373::ENST00000442448.1(ERG):r.124_5034	21	-	ENST00000332149.5	3.0	42866283.0	42866283.0	42880086.0	42880086.0	21	-	ENST00000442448.1	2.0	39751952.0	39751952.0	39956869.0	39956869.0	Inferred Breakpoint	16951141
COSF1397	COL1A1	USP6	bone	tibia	other	aneurysmal bone cyst	COSO282218308	ENST00000225964.5(COL1A1):r.1_222::ENST00000250066.6(USP6):r.1699_7976	17	-	ENST00000225964.5	1.0	48278772.0	48278772.0	48278993.0	48278993.0	17	+	ENST00000250066.6	2.0	5033662.0	5033662.0	5078329.0	5078329.0	Inferred Breakpoint	18068538
COSF1399	CDH11	USP6	bone	NS	other	aneurysmal bone cyst	COSO280618308	ENST00000268603.4(CDH11):r.1_319::ENST00000250066.6(USP6):r.1_7976	16	-	ENST00000268603.4	1.0	65155783.0	65155783.0	65156101.0	65156101.0	17	+	ENST00000250066.6	1.0	5031687.0	5031687.0	5078329.0	5078329.0	Inferred Breakpoint	15026324
COSF14	TMPRSS2	ETV1	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000332149.5(TMPRSS2):r.1_79::ENST00000430479.1(ETV1):r.850_6740	21	-	ENST00000332149.5	1.0	42880008.0	42880008.0	42880086.0	42880086.0	7	-	ENST00000430479.1	6.0	13930853.0	13930853.0	14017105.0	14017105.0	Observed mRNA	16254181
COSF1410	THRAP3	USP6	bone	tibia	other	aneurysmal bone cyst	COSO282218308	ENST00000354618.5(THRAP3):r.1_59::ENST00000250066.6(USP6):r.1_7976	1	+	ENST00000354618.5	1.0	36690017.0	36690017.0	36690075.0	36690075.0	17	+	ENST00000250066.6	1.0	5031687.0	5031687.0	5078329.0	5078329.0	Observed mRNA	15735689
COSF1412	OMD	USP6	bone	clavicle	other	aneurysmal bone cyst	COSO586818308	ENST00000375550.4(OMD):r.1_260::ENST00000250066.6(USP6):r.1_7976	9	-	ENST00000375550.4	1.0	95186484.0	95186484.0	95186743.0	95186743.0	17	+	ENST00000250066.6	1.0	5031687.0	5031687.0	5078329.0	5078329.0	Inferred Breakpoint	15735689
COSF1416	CNBP	USP6	bone	tibia	other	aneurysmal bone cyst	COSO282218308	ENST00000422453.2(CNBP):r.1_147::ENST00000250066.6(USP6):r.1699_7976	3	-	ENST00000422453.2	1.0	128902619.0	128902619.0	128902765.0	128902765.0	17	+	ENST00000250066.6	2.0	5033662.0	5033662.0	5078329.0	5078329.0	Observed mRNA	15735689
COSF1432	IRF2BP2	CDX1	bone	extraskeletal	chondrosarcoma	mesenchymal	COSO521410457	ENST00000366609.3(IRF2BP2):r.1_1079::ENST00000231656.8(CDX1):r.528_1757	1	-	ENST00000366609.3	1.0	234744193.0	234744193.0	234745271.0	234745271.0	5	+	ENST00000231656.8	2.0	149562331.0	149562331.0	149564120.0	149564120.0	Observed mRNA	23185413
COSF145	EWSR1	ERG	bone	NS	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO28065222	ENST00000397938.2(EWSR1):r.1_1112::ENST00000442448.1(ERG):r.1141_5034	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	21	-	ENST00000442448.1	11.0	39751952.0	39751952.0	39755845.0	39755845.0	Observed mRNA	7591257
COSF1489	TCF3	PBX1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic leukaemia	COSO29914826	ENST00000262965.5(TCF3):r.1_1795::ENST00000420696.2(PBX1):r.454_6636	19	-	ENST00000262965.5	16.0	1619110.0	1619110.0	1652604.0	1652604.0	1	+	ENST00000420696.2	3.0	164761731.0	164761731.0	164821068.0	164821068.0	Observed mRNA	23688269
COSF1622	CDKN2D	WDFY2	ovary	NS	carcinoma	serous carcinoma	COSO30135468	ENST00000335766.2(CDKN2D):r.1_269::ENST00000298125.5(WDFY2):r.386_3649	19.0	-	ENST00000335766.2	2.0	10679189.0	10679189.0	10679735.0	10679735.0	13	+	ENST00000298125.5	3.0	52249306.0	52249306.0	52336171.0	52336171.0	Observed mRNA	24675677
COSF163	EWSR1	ETV1	bone	extraskeletal	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO52145222	ENST00000397938.2(EWSR1):r.1_1112::ENST00000430479.1(ETV1):r.1609_6740	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	7	-	ENST00000430479.1	12.0	13930853.0	13930853.0	13946224.0	13946224.0	Observed mRNA	7700648
COSF1739	BCR	ABL1	blood-lymph	NS	haematopoietic neoplasm	chronic myeloid leukaemia	COSO27985050	ENST00000305877.8(BCR):r.1_2819::ENST00000318560.5(ABL1):r.461_5766	22.0	+	ENST00000305877.8	8.0	23522397.0	23522397.0	23615914.0	23615914.0	9	+	ENST00000318560.5	2.0	133729451.0	133729451.0	133763062.0	133763062.0	Observed mRNA	10233416
COSF1784	KMT2A	AFF3	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000534358.1(KMT2A):r.1_4109::ENST00000409579.1(AFF3):r.1230_4342	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	2	-	ENST00000409579.1	9.0	100167583.0	100167583.0	100368763.0	100368763.0	Observed mRNA	12203795
COSF1786	KMT2A	MLLT1	blood-lymph	NS	haematopoietic neoplasm	blastic plasmacytoid dendritic cell neoplasm	COSO279817473	ENST00000534358.1(KMT2A):r.1_4109::ENST00000252674.7(MLLT1):r.711_1931	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	19	-	ENST00000252674.7	6.0	6212966.0	6212966.0	6222695.0	6222695.0	Observed mRNA	21831428
COSF1795	KMT2A	FOXO3	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO27984985	ENST00000534358.1(KMT2A):r.1_4241::ENST00000343882.6(FOXO3):r.926_7308	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	6	+	ENST00000343882.6	3.0	108984658.0	108984658.0	109005977.0	109005977.0	Inferred Breakpoint	9345057
COSF1797	KMT2A	AFF4	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000534358.1(KMT2A):r.1_4241::ENST00000265343.5(AFF4):r.1431_9552	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	5	-	ENST00000265343.5	6.0	132211071.0	132211071.0	132240096.0	132240096.0	Observed mRNA	10588740
COSF1799	KMT2A	AFF1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic leukaemia	COSO27984916	ENST00000534358.1(KMT2A):r.1_4109::ENST00000307808.6(AFF1):r.1933_9390	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	4	+	ENST00000307808.6	11.0	88035519.0	88035519.0	88062190.0	88062190.0	Inferred Breakpoint	12433702
COSF1806	KMT2A	AFDN	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4109::ENST00000392108.3(AFDN):r.248_6812	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	6	+	ENST00000392108.3	2.0	168265231.0	168265231.0	168364976.0	168364976.0	Inferred Breakpoint	8242616
COSF1817	KMT2A	LPP	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO27984995	ENST00000534358.1(KMT2A):r.1_4355::ENST00000312675.4(LPP):r.1657_18278	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118355690.0	118355690.0	3	+	ENST00000312675.4	9.0	188583988.0	188583988.0	188608460.0	188608460.0	Observed mRNA	11433529
COSF1833	KMT2A	CIP2A	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984972	ENST00000534358.1(KMT2A):r.1_4241::ENST00000295746.8(CIP2A):r.2091_4075	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	3	-	ENST00000295746.8	17.0	108268716.0	108268716.0	108276261.0	108276261.0	Observed mRNA	20943269
COSF1835	KMT2A	ABI2	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984905	ENST00000534358.1(KMT2A):r.1_4109::ENST00000261017.5(ABI2):r.698_6484	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	2	+	ENST00000261017.5	4.0	204255769.0	204255769.0	204296896.0	204296896.0	Observed mRNA	22304832
COSF1839	KMT2A	SORBS2	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984972	ENST00000534358.1(KMT2A):r.1_4241::ENST00000284776.7(SORBS2):r.3595_5996	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	4	-	ENST00000284776.7	19.0	186506598.0	186506598.0	186515089.0	186515089.0	Observed mRNA	16628191
COSF1841	KMT2A	GMPS	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO27984961	ENST00000534358.1(KMT2A):r.?::ENST00000496455.2(GMPS):r.?			ENST00000534358.1								ENST00000496455.2						Inferred Breakpoint	11110714
COSF1842	KMT2A	PDS5A	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27985021	ENST00000534358.1(KMT2A):r.1_4109::ENST00000303538.8(PDS5A):r.2171_7176	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	4	-	ENST00000303538.8	16.0	39824483.0	39824483.0	39900148.0	39900148.0	Observed mRNA	22230297
COSF1844	KMT2A	SEPT5	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984912	ENST00000534358.1(KMT2A):r.1_4241::ENST00000455784.2(SEPT5):r.180_2070	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	22	+	ENST00000455784.2	3.0	19707125.0	19707125.0	19710842.0	19710842.0	Observed mRNA	9600980
COSF1846	KMT2A	ARHGEF12	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4109::ENST00000397843.2(ARHGEF12):r.1091_9660	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	11	+	ENST00000397843.2	12.0	120308017.0	120308017.0	120360645.0	120360645.0	Observed mRNA	10681437
COSF1848	KMT2A	SARNP	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4109::ENST00000336133.3(SARNP):r.92_926	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	12	-	ENST00000336133.3	2.0	56151058.0	56151058.0	56197512.0	56197512.0	Inferred Breakpoint	15284855
COSF1850	KMT2A	GPHN	blood-lymph	NS	haematopoietic neoplasm	acute leukaemia of ambiguous lineage therapy related	COSO279819420	ENST00000534358.1(KMT2A):r.1_4241::ENST00000478722.1(GPHN):r.2085_4297	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	14	+	ENST00000478722.1	10.0	67490350.0	67490350.0	67648520.0	67648520.0	Observed mRNA	11579461
COSF1853	KMT2A	DAB2IP	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984972	ENST00000534358.1(KMT2A):r.1_4109::ENST00000309989.1(DAB2IP):r.292_3500	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	9	+	ENST00000309989.1	3.0	124521177.0	124521177.0	124544932.0	124544932.0	Observed mRNA	14978793
COSF1856	KMT2A	MLLT3	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27985021	ENST00000534358.1(KMT2A):r.1_4355::ENST00000380338.4(MLLT3):r.1413_6772	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118355690.0	118355690.0	9	-	ENST00000380338.4	6.0	20341663.0	20341663.0	20365742.0	20365742.0	Inferred Breakpoint	8414510
COSF1862	CENPK	KMT2A	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27985021	ENST00000396679.1(CENPK):r.1_503::ENST00000534358.1(KMT2A):r.4110_16594	5.0	-	ENST00000396679.1	6.0	64838629.0	64838629.0	64858998.0	64858998.0	11	+	ENST00000534358.1	9.0	118354898.0	118354898.0	118397539.0	118397539.0	Observed mRNA	8950979
COSF1864	KMT2A	ABI1	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4241::ENST00000376142.2(ABI1):r.358_3576	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	10	-	ENST00000376142.2	3.0	27035522.0	27035522.0	27066170.0	27066170.0	Observed mRNA	9694699
COSF1869	KMT2A	KNL1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic T cell leukaemia	COSO27984908	ENST00000534358.1(KMT2A):r.1_4109::ENST00000346991.5(KNL1):r.5845_9573	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	15	+	ENST00000346991.5	12.0	40920268.0	40920268.0	40956540.0	40956540.0	Observed mRNA	12618768
COSF1872	KMT2A	ZFYVE19	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984912	ENST00000534358.1(KMT2A):r.1_4027::ENST00000355341.4(ZFYVE19):r.939_2260	11.0	+	ENST00000534358.1	7.0	118307205.0	118307205.0	118352799.0	118352799.0	15	+	ENST00000355341.4	3.0	41101642.0	41101642.0	41106767.0	41106767.0	Observed mRNA	12618766
COSF1874	KMT2A	CREBBP	blood-lymph	NS	haematopoietic neoplasm	myelodysplastic syndrome	COSO27985143	ENST00000534358.1(KMT2A):r.1_4355::ENST00000262367.5(CREBBP):r.1609_10803	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118355690.0	118355690.0	16	-	ENST00000262367.5	3.0	3775055.0	3775055.0	3860780.0	3860780.0	Inferred Breakpoint	9166831
COSF1882	KMT2A	MLLT6	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27985024	ENST00000534358.1(KMT2A):r.1_4109::ENST00000325718.7(MLLT6):r.911_7578	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	17	+	ENST00000325718.7	9.0	36871865.0	36871865.0	36886056.0	36886056.0	Observed mRNA	16105757
COSF1884	KMT2A	MYO1F	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27985024	ENST00000534358.1(KMT2A):r.1_4241::ENST00000338257.8(MYO1F):r.272_4303	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	19	-	ENST00000338257.8	2.0	8585674.0	8585674.0	8620680.0	8620680.0	Observed mRNA	15897884
COSF1886	KMT2A	LASP1	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4241::ENST00000318008.6(LASP1):r.944_4109	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	17	+	ENST00000318008.6	7.0	37074858.0	37074858.0	37078023.0	37078023.0	Observed mRNA	12527918
COSF1890	KMT2A	GAS7	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000534358.1(KMT2A):r.1_4241::ENST00000432992.2(GAS7):r.345_4970	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	17	-	ENST00000432992.2	2.0	9817167.0	9817167.0	9923214.0	9923214.0	Observed mRNA	16956839
COSF1895	KMT2A	TOP3A	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984905	ENST00000534358.1(KMT2A):r.1_4241::ENST00000321105.5(TOP3A):r.171_4056	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	17	-	ENST00000321105.5	1.0	18177281.0	18177281.0	18218137.0	18218137.0	Observed mRNA	22050635
COSF1898	KMT2A	TET1	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia associated with MDS	COSO279811382	ENST00000534358.1(KMT2A):r.1_4109::ENST00000373644.4(TET1):r.5034_9288	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	10	+	ENST00000373644.4	9.0	70441156.0	70441156.0	70454239.0	70454239.0	Observed mRNA	12124344
COSF1902	KMT2A	MAPRE1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000534358.1(KMT2A):r.1_4109::ENST00000375571.5(MAPRE1):r.737_2623	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	20	+	ENST00000375571.5	6.0	31434424.0	31434424.0	31438211.0	31438211.0	Observed mRNA	15751040
COSF1906	KMT2A	EP300	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO27984959	ENST00000534358.1(KMT2A):r.1_4355::ENST00000263253.7(EP300):r.4037_9585	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118355690.0	118355690.0	22	+	ENST00000263253.7	15.0	41547837.0	41547837.0	41576081.0	41576081.0	Observed mRNA	18778367
COSF1914	KMT2A	SH3GL1	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984905	ENST00000534358.1(KMT2A):r.1_4109::ENST00000269886.3(SH3GL1):r.225_2516	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	19	-	ENST00000269886.3	2.0	4360367.0	4360367.0	4366991.0	4366991.0	Observed mRNA	9122235
COSF1916	KMT2A	SEPT6	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4355::ENST00000343984.5(SEPT6):r.296_2693	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118355690.0	118355690.0	X	-	ENST00000343984.5	2.0	118751602.0	118751602.0	118809631.0	118809631.0	Observed mRNA	14506700
COSF1927	KMT2A	SEPT9	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984905	ENST00000534358.1(KMT2A):r.1_4035::ENST00000427177.1(SEPT9):r.203_3821	11.0	+	ENST00000534358.1	7.0	118307205.0	118307205.0	118352807.0	118352807.0	17	+	ENST00000427177.1	3.0	75398141.0	75398141.0	75496674.0	75496674.0	Observed mRNA	20113838
COSF1936	KMT2A	ARHGAP26	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984972	ENST00000534358.1(KMT2A):r.1_4109::ENST00000274498.4(ARHGAP26):r.1486_6862	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	5	+	ENST00000274498.4	12.0	142393645.0	142393645.0	142606050.0	142606050.0	Observed mRNA	15852479
COSF1944	KMT2A	NCKIPSD	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO279819416	ENST00000534358.1(KMT2A):r.1_4109::ENST00000294129.2(NCKIPSD):r.292_2989	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	3	-	ENST00000294129.2	2.0	48711277.0	48711277.0	48720445.0	48720445.0	Observed mRNA	10648423
COSF1965	KMT2A	MLLT11	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4109::ENST00000368921.3(MLLT11):r.2797_4072	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	1	+	ENST00000368921.3	2.0	151039695.0	151039695.0	151040970.0	151040970.0	Observed mRNA	7833468
COSF1966	KMT2A	PICALM	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27985024	ENST00000534358.1(KMT2A):r.1_4241::ENST00000393346.3(PICALM):r.915_2340	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	11	-	ENST00000393346.3	8.0	85669857.0	85669857.0	85718626.0	85718626.0	Observed mRNA	12461747
COSF1968	KMT2A	FRYL	blood-lymph	NS	haematopoietic neoplasm	myelodysplastic syndrome therapy related	COSO27985178	ENST00000534358.1(KMT2A):r.1_4355+2329::ENST00000358350.4(FRYL):r.7509-1397_11706	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118358019.0	118358019.0	4	-	ENST00000358350.4	51.0	48499380.0	48499380.0	48531750.0	48531750.0	Inferred Breakpoint	18195096
COSF1970	KMT2A	CBL	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984910	ENST00000534358.1(KMT2A):r.1_4109::ENST00000264033.4(CBL):r.1808_11465	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	11	+	ENST00000264033.4	10.0	119155679.0	119155679.0	119178859.0	119178859.0	Observed mRNA	12696071
COSF1972	KMT2A	SEPT2	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO27984961	ENST00000534358.1(KMT2A):r.1_4241::ENST00000360051.3(SEPT2):r.450_3613	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	2	+	ENST00000360051.3	4.0	242265408.0	242265408.0	242293439.0	242293439.0	Observed mRNA	16682951
COSF1976	KMT2A	FOXO4	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic T cell leukaemia	COSO27984908	ENST00000534358.1(KMT2A):r.1_4355+1753::ENST00000374259.3(FOXO4):r.786-791_3301	11.0	+	ENST00000534358.1	10.0	118307205.0	118307205.0	118357443.0	118357443.0	X	+	ENST00000374259.3	2.0	70319743.0	70319743.0	70323385.0	70323385.0	Inferred Breakpoint	9010221
COSF198	NPM1	ALK	blood-lymph	NS	lymphoid neoplasm	anaplastic large cell lymphoma	COSO27986820	ENST00000517671.1(NPM1):r.1_487::ENST00000389048.3(ALK):r.4080_6220	5	+	ENST00000517671.1	5.0	170814120.0	170814120.0	170818803.0	170818803.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Observed mRNA	8122112
COSF1988	KMT2A	ELL	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4241::ENST00000262809.4(ELL):r.208_4027	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118355029.0	118355029.0	19	-	ENST00000262809.4	2.0	18553473.0	18553473.0	18583692.0	18583692.0	Inferred Breakpoint	7991593
COSF1998	KMT2A	EPS15	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984965	ENST00000534358.1(KMT2A):r.1_4109::ENST00000371733.3(EPS15):r.131_5225	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	1	-	ENST00000371733.3	2.0	51819935.0	51819935.0	51946986.0	51946986.0	Inferred Breakpoint	8134107
COSF2025	KMT2A	ACTN4	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia therapy related	COSO279819440	ENST00000534358.1(KMT2A):r.1_4109::ENST00000252699.2(ACTN4):r.239_4963	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	19	+	ENST00000252699.2	2.0	39191240.0	39191240.0	39222223.0	39222223.0	Observed mRNA	24561789
COSF2033	KMT2A	MLLT10	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984914	ENST00000534358.1(KMT2A):r.1_4109::ENST00000377072.3(MLLT10):r.2275_5126	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	10	+	ENST00000377072.3	16.0	22015173.0	22015173.0	22032559.0	22032559.0	Inferred Breakpoint	23278644
COSF2053	KMT2A	NRIP3	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984972	ENST00000534358.1(KMT2A):r.?::ENST00000309166.3(NRIP3):r.?			ENST00000534358.1								ENST00000309166.3						Inferred Breakpoint	19454493
COSF2054	KMT2A	BTBD18	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000534358.1(KMT2A):r.1_4147::ENST00000422652.1(BTBD18):r.583_3044	11.0	+	ENST00000534358.1	9.0	118307205.0	118307205.0	118354935.0	118354935.0	11	-	ENST00000422652.1	3.0	57510990.0	57510990.0	57513451.0	57513451.0	Observed mRNA	20598370
COSF2058	KMT2A	CASP8AP2	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984912	ENST00000534358.1(KMT2A):r.1_4035+138::ENST00000551025.1(CASP8AP2):r.4100-640_7344	11.0	+	ENST00000534358.1	7.0	118307205.0	118307205.0	118352945.0	118352945.0			ENST00000551025.1						Inferred Breakpoint	19837277
COSF2059	KMT2A	CEP170B	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia therapy related	COSO27984959	ENST00000534358.1(KMT2A):r.1_4109+946::ENST00000414716.3(CEP170B):r.562-1539_6705	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118354156.0	118354156.0	14	+	ENST00000414716.3	6.0	105345085.0	105345085.0	105363107.0	105363107.0	Inferred Breakpoint	19254855
COSF2063	KMT2A	PRRC1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia therapy related	COSO279819440	ENST00000534358.1(KMT2A):r.?::ENST00000296666.8(PRRC1):r.?			ENST00000534358.1								ENST00000296666.8						Inferred Breakpoint	25205603
COSF2064	KMT2A	EEFSEC	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000534358.1(KMT2A):r.?::ENST00000254730.6(EEFSEC):r.?			ENST00000534358.1								ENST00000254730.6						Inferred Breakpoint	17268512
COSF2070	KMT2A	CT45A2	blood-lymph	NS	haematopoietic neoplasm	acute leukaemia of ambiguous lineage	COSO27984903	ENST00000534358.1(KMT2A):r.1_4109::ENST00000370736.3(CT45A2):r.240_1010	11.0	+	ENST00000534358.1	8.0	118307205.0	118307205.0	118353210.0	118353210.0	X	+	ENST00000370736.3	2.0	134869958.0	134869958.0	134874250.0	134874250.0	Observed mRNA	20920256
COSF208	EWSR1	ETV4	bone	extraskeletal	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO52145222	ENST00000397938.2(EWSR1):r.1_1112::ENST00000319349.5(ETV4):r.1111_2429	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	17	-	ENST00000319349.5	9.0	41605212.0	41605212.0	41607549.0	41607549.0	Observed mRNA	8605035
COSF212	TMPRSS2	ETV4	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000332149.5(TMPRSS2):r.1-(8047)_1-(8000)::ENST00000319349.5(ETV4):r.360-19_2429	21	-	ENST00000332149.5	1.0					17	-	ENST00000319349.5	3.0	41605212.0	41605212.0	41622754.0	41622754.0	Observed mRNA	16585160
COSF2150	STIL	TAL1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic T cell leukaemia	COSO27984908	ENST00000360380.3(STIL):r.1_112+308_insTTA::ENST00000371884.2(TAL1):r.1-183_4642	1.0	-	ENST00000360380.3	1.0	47779400.0	47779400.0	47779819.0	47779819.0	1	-	ENST00000371884.2	1.0	47681962.0	47681962.0	47697570.0	47697570.0	Inferred Breakpoint	8350619
COSF219	EWSR1	ATF1	bone	humerus	dermatofibroma	aneurysmal fibrous histiocytoma	COSO353710062	ENST00000397938.2(EWSR1):r.1_1112::ENST00000262053.3(ATF1):r.351_2181	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	12	+	ENST00000262053.3	5.0	51207793.0	51207793.0	51214905.0	51214905.0	Inferred Breakpoint	10504528
COSF2217	DNAJB1	PRKACA	liver	NS	carcinoma	fibrolamellar carcinoma	COSO29825600	ENST00000254322.2(DNAJB1):r.1_282::ENST00000308677.4(PRKACA):r.245_2677	19.0	-	ENST00000254322.2	1.0	14628951.0	14628951.0	14629232.0	14629232.0	19	-	ENST00000308677.4	2.0	14202500.0	14202500.0	14218220.0	14218220.0	Observed mRNA	25557953
COSF2245	ETV6	RUNX1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000396373.4(ETV6):r.1_1283::ENST00000300305.3(RUNX1):r.504_6222	12.0	+	ENST00000396373.4	5.0	11802788.0	11802788.0	12022903.0	12022903.0	21.0	-	ENST00000300305.3	2.0	36160098.0	36160098.0	36265260.0	36265260.0	Inferred Breakpoint	8751464
COSF2287	CBFA2T3	GLIS2	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984952	ENST00000268679.4(CBFA2T3):r.1_2278::ENST00000262366.3(GLIS2):r.945_4469	16.0	-	ENST00000268679.4	12.0	88943465.0	88943465.0	89043612.0	89043612.0	16.0	+	ENST00000262366.3	3.0	4382405.0	4382405.0	4389598.0	4389598.0	Observed mRNA	23153540
COSF2291	NUP98	KDM5A	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984952	ENST00000324932.7(NUP98):r.1_1963::ENST00000399788.2(KDM5A):r.4819_10763	11.0	-	ENST00000324932.7	13.0	3756421.0	3756421.0	3819022.0	3819022.0	12.0	-	ENST00000399788.2	27.0	389295.0	389295.0	402335.0	402335.0	Observed mRNA	23153540
COSF2297	DHH	RHEBL1	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984905	ENST00000266991.2(DHH):r.1_872::ENST00000301068.6(RHEBL1):r.293_1210	12.0	-	ENST00000266991.2	2.0	49484911.0	49484911.0	49488602.0	49488602.0	12.0	-	ENST00000301068.6	2.0	49458468.0	49458468.0	49462889.0	49462889.0	Inferred Breakpoint	24127550
COSF2299	PML	RARA	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984969	ENST00000268058.3(PML):r.1_1753::ENST00000254066.5(RARA):r.634_2414	15.0	+	ENST00000268058.3	6.0	74287058.0	74287058.0	74325755.0	74325755.0	17.0	+	ENST00000254066.5	3.0	38504568.0	38504568.0	38513048.0	38513048.0	Observed mRNA	15899384
COSF2323	SET	NUP214	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic T cell leukaemia	COSO27984908	ENST00000322030.8(SET):r.1_1167::ENST00000359428.5(NUP214):r.2581_7600	9.0	+	ENST00000322030.8	7.0	131451505.0	131451505.0	131456321.0	131456321.0	9	+	ENST00000359428.5	18.0	134034770.0	134034770.0	134110057.0	134110057.0	Observed mRNA	20065082
COSF2334	EWSR1	MYB	blood-lymph	NS	haematopoietic neoplasm	acute leukaemic transformation of primary myelofibrosis	COSO279818352	ENST00000397938.2(EWSR1):r.1_900::ENST00000341911.5(MYB):r.223_3672	22.0	+	ENST00000397938.2	6.0	29664007.0	29664007.0	29678546.0	29678546.0	6.0	+	ENST00000341911.5	2.0	135507041.0	135507041.0	135540305.0	135540305.0	Observed mRNA	27594918
COSF2336	NUP214	ABL1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic T cell leukaemia	COSO27984908	ENST00000359428.5(NUP214):r.1_3463::ENST00000318560.5(ABL1):r.461_5766	9.0	+	ENST00000359428.5	23.0	134000948.0	134000948.0	134051008.0	134051008.0	9.0	+	ENST00000318560.5	2.0	133729451.0	133729451.0	133763062.0	133763062.0	Inferred Breakpoint	15361874
COSF2362	ETV6	ABL1	blood-lymph	NS	lymphoid neoplasm	acute lymphoblastic B cell leukaemia	COSO27984920	ENST00000396373.4(ETV6):r.1_1283::ENST00000318560.5(ABL1):r.461_5766	12.0	+	ENST00000396373.4	5.0	11802788.0	11802788.0	12022903.0	12022903.0	9.0	+	ENST00000318560.5	2.0	133729451.0	133729451.0	133763062.0	133763062.0	Observed mRNA	27229714
COSF2367	TBL1XR1	TP63	blood-lymph	NS	lymphoid neoplasm	diffuse large B cell lymphoma	COSO27984818	ENST00000430069.1(TBL1XR1):r.1_962::ENST00000264731.3(TP63):r.414_4909	3.0	-	ENST00000430069.1	7.0	176767785.0	176767785.0	176914266.0	176914266.0	3.0	+	ENST00000264731.3	4.0	189526061.0	189526061.0	189615068.0	189615068.0	Observed mRNA	22496164
COSF2377	RUNX1	RUNX1T1	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO279818357	ENST00000300305.3(RUNX1):r.1_1058::ENST00000360348.2(RUNX1T1):r.189_2370	21	-	ENST00000300305.3	5.0	36231771.0	36231771.0	36421641.0	36421641.0	8	-	ENST00000360348.2	2.0	92972015.0	92972015.0	93029591.0	93029591.0	Observed mRNA	16956837
COSF2401	MN1	ETV6	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia associated with MDS	COSO27984983	ENST00000302326.4(MN1):r.1_4736::ENST00000396373.4(ETV6):r.438_5989	22.0	-	ENST00000302326.4	1.0	28192751.0	28192751.0	28197486.0	28197486.0	12.0	+	ENST00000396373.4	3.0	11992074.0	11992074.0	12048336.0	12048336.0	Observed mRNA	21600651
COSF2409	ETV6	PDGFRB	blood-lymph	NS	haematopoietic neoplasm	acute myeloid leukaemia	COSO27984905	ENST00000396373.4(ETV6):r.1_737::ENST00000261799.4(PDGFRB):r.2050_5717	12	+	ENST00000396373.4	4.0	11802788.0	11802788.0	12006495.0	12006495.0	5	-	ENST00000261799.4	11.0	149493400.0	149493400.0	149506177.0	149506177.0	Inferred Breakpoint	21233837
COSF295	FUS	FEV	bone	clavicle	Ewing sarcoma-peripheral primitive neuroectodermal tumour	NS	COSO58685222	ENST00000254108.7(FUS):r.1_1171::ENST00000295727.1(FEV):r.635_1879	16	+	ENST00000254108.7	10.0	31191431.0	31191431.0	31201115.0	31201115.0	2	-	ENST00000295727.1	2.0	219845809.0	219845809.0	219849027.0	219849027.0	Inferred Breakpoint	17620387
COSF309	FUS	ERG	bone	extraskeletal	Askins tumour	NS	COSO521410967	ENST00000254108.7(FUS):r.1_859::ENST00000442448.1(ERG):r.1141_5034	16	+	ENST00000254108.7	6.0	31191431.0	31191431.0	31196490.0	31196490.0	21	-	ENST00000442448.1	11.0	39751952.0	39751952.0	39755845.0	39755845.0	Observed mRNA	12907633
COSF322	EWSR1	POU5F1	bone	pelvis	undifferentiated sarcoma	NS	COSO281822055	ENST00000397938.2(EWSR1):r.1_900+?::ENST00000259915.8(POU5F1):r.419_1414	22	+	ENST00000397938.2	6.0	29664007.0	29664007.0	29678546.0	29682911.0	6	-	ENST00000259915.8	1.0	31132120.0	31132120.0	31138052.0	31138052.0	Inferred Breakpoint	15729702
COSF345	EWSR1	ZNF384	blood-lymph	NS	haematopoietic neoplasm	acute leukaemia of ambiguous lineage	COSO27984903	ENST00000397938.2(EWSR1):r.1_1112::ENST00000396795.1(ZNF384):r.439_3286	22	+	ENST00000397938.2	7.0	29664007.0	29664007.0	29683123.0	29683123.0	12	-	ENST00000396795.1	1.0	6775643.0	6775643.0	6797387.0	6797387.0	Observed mRNA	12359745
COSF352	EWSR1	NR4A3	bone	extraskeletal	chondrosarcoma	myxoid	COSO52146410	ENST00000397938.2(EWSR1):r.1_1613::ENST00000395097.2(NR4A3):r.728_3794	22	+	ENST00000397938.2	12.0	29664007.0	29664007.0	29692358.0	29692358.0	9	+	ENST00000395097.2	3.0	102590323.0	102590323.0	102627333.0	102627333.0	Inferred Breakpoint	11679947
COSF393	ASPSCR1	TFE3	kidney	NS	carcinoma	TFE3-rearranged renal cell carcinoma	COSO37256182	ENST00000306739.4(ASPSCR1):r.1_1030::ENST00000315869.7(TFE3):r.1146_3415	17	+	ENST00000306739.4	7.0	79935426.0	79935426.0	79954722.0	79954722.0	X	-	ENST00000315869.7	6.0	48886242.0	48886242.0	48891766.0	48891766.0	Inferred Breakpoint	11244503
COSF415	RANBP2	ALK	blood-lymph	NS	haematopoietic neoplasm	myelodysplastic syndrome	COSO375611111	ENST00000283195.6(RANBP2):r.1_2728::ENST00000389048.3(ALK):r.4080_6220	2	+	ENST00000283195.6	18.0	109335937.0	109335937.0	109375004.0	109375004.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	18701132
COSF421	MSN	ALK	blood-lymph	lymph node	lymphoid neoplasm	anaplastic large cell lymphoma	COSO27606820	ENST00000360270.5(MSN):r.1_1516::ENST00000389048.3(ALK):r.4097_6220	X	+	ENST00000360270.5	11.0	64887537.0	64887537.0	64958479.0	64958479.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446377.0	29446377.0	Observed mRNA	11310834
COSF424	TFG	ALK	blood-lymph	lymph node	lymphoid neoplasm	anaplastic large cell lymphoma	COSO27606820	ENST00000240851.4(TFG):r.1_755::ENST00000389048.3(ALK):r.4080_6220	3	+	ENST00000240851.4	4.0	100428269.0	100428269.0	100447702.0	100447702.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Observed mRNA	10556217
COSF434	CLTC	ALK	blood-lymph	lymph node	lymphoid neoplasm	anaplastic large cell lymphoma	COSO27606820	ENST00000269122.3(CLTC):r.1_5177::ENST00000389048.3(ALK):r.4080_6220	17	+	ENST00000269122.3	31.0	57697219.0	57697219.0	57768072.0	57768072.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	10807789
COSF439	TPM3	ALK	blood-lymph	lymph node	lymphoid neoplasm	anaplastic large cell lymphoma	COSO27606820	ENST00000368533.3(TPM3):r.1_717::ENST00000389048.3(ALK):r.4080_6220	1	-	ENST00000368533.3	7.0	154142876.0	154142876.0	154155648.0	154155648.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	17464320
COSF441	TPM4	ALK	blood-lymph	NS	lymphoid neoplasm	anaplastic large cell lymphoma	COSO377311111	ENST00000300933.4(TPM4):r.1_924::ENST00000389048.3(ALK):r.4080_6220	19	+	ENST00000300933.4	7.0	16187116.0	16187116.0	16204563.0	16204563.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	10934142
COSF444	ATIC	ALK	blood-lymph	lymph node	lymphoid neoplasm	anaplastic large cell lymphoma	COSO27606820	ENST00000236959.9(ATIC):r.1_1014::ENST00000389048.3(ALK):r.4080_6220	2	+	ENST00000236959.9	7.0	216176540.0	216176540.0	216191701.0	216191701.0	2	-	ENST00000389048.3	20.0	29415640.0	29415640.0	29446394.0	29446394.0	Inferred Breakpoint	17464320
COSF495	ETV6	NTRK3	breast	NS	carcinoma	ductal carcinoma	COSO28399765	ENST00000396373.4(ETV6):r.?::ENST00000394480.2(NTRK3):r.?			ENST00000396373.4								ENST00000394480.2						Inferred Breakpoint	15101049
COSF589	TAF15	NR4A3	bone	extraskeletal	chondrosarcoma	myxoid	COSO52146410	ENST00000311979.3(TAF15):r.?::ENST00000395097.2(NR4A3):r.?			ENST00000311979.3								ENST00000395097.2						Inferred Breakpoint	18580682
COSF610	TFG	NR4A3	bone	extraskeletal	chondrosarcoma	myxoid	COSO52146410	ENST00000240851.4(TFG):r.1_1160::ENST00000395097.2(NR4A3):r.728_3794	3	+	ENST00000240851.4	7.0	100428269.0	100428269.0	100463775.0	100463775.0	9	+	ENST00000395097.2	3.0	102590323.0	102590323.0	102627333.0	102627333.0	Inferred Breakpoint	15188455
COSF665	RGS22	SYCP1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000360863.6(RGS22):r.1_3555::ENST00000369518.1(SYCP1):r.2100_3452	8.0	-	ENST00000360863.6	22.0	100994165.0	100994165.0	101118344.0	101118344.0	1.0	+	ENST00000369518.1	24.0	115486960.0	115486960.0	115537988.0	115537988.0	Observed mRNA	20033038
COSF667	ERO1A	FERMT2	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000395686.3(ERO1A):r.1_658::ENST00000395631.2(FERMT2):r.744_3369	14.0	-	ENST00000395686.3	5.0	53138513.0	53138513.0	53162423.0	53162423.0	14.0	-	ENST00000395631.2	5.0	53323986.0	53323986.0	53348187.0	53348187.0	Observed mRNA	20033038
COSF669	NFIA	EHF	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000485903.2(NFIA):r.1_625::ENST00000257831.3(EHF):r.528_3150	1.0	+	ENST00000485903.2	2.0	61548395.0	61548395.0	61554349.0	61554349.0	11.0	+	ENST00000257831.3	5.0	34673089.0	34673089.0	34682604.0	34682604.0	Observed mRNA	20033038
COSF671	SLC26A6	PRKAR2A	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000395550.2(SLC26A6):r.1_1941::ENST00000265563.8(PRKAR2A):r.602_6471	3.0	-	ENST00000395550.2	17.0	48665379.0	48665379.0	48672874.0	48672874.0	3.0	-	ENST00000265563.8	4.0	48784012.0	48784012.0	48828060.0	48828060.0	Observed mRNA	20033038
COSF673	MBOAT2	PRKCE	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000305997.3(MBOAT2):r.1_705::ENST00000306156.3(PRKCE):r.1920_5650	2.0	-	ENST00000305997.3	6.0	9022641.0	9022641.0	9143942.0	9143942.0	2.0	+	ENST00000306156.3	12.0	46372232.0	46372232.0	46415129.0	46415129.0	Inferred Breakpoint	20033038
COSF675	RAF1	DAZL	breast	NS	carcinoma	NS	COSO28394862	ENST00000251849.4(RAF1):r.1_1274::ENST00000399444.2(DAZL):r.298_3050	3	-	ENST00000251849.4	7.0	12645635.0	12645635.0	12705725.0	12705725.0	3	-	ENST00000399444.2	2.0	16628299.0	16628299.0	16640105.0	16640105.0	Observed mRNA	20033038
COSF677	SEPT8	AFF4	breast	NS	carcinoma	NS	COSO28394862	ENST00000296873.7(SEPT8):r.1_314::ENST00000265343.5(AFF4):r.3480_9552	5	-	ENST00000296873.7	1.0	132112800.0	132112800.0	132113113.0	132113113.0	5	-	ENST00000265343.5	19.0	132211071.0	132211071.0	132220811.0	132220811.0	Inferred Breakpoint	20033038
COSF679	ETV6	ITPR2	breast	NS	carcinoma	NS	COSO28394862	ENST00000396373.4(ETV6):r.1_437::ENST00000381340.3(ITPR2):r.5048_10511	12	+	ENST00000396373.4	2.0	11802788.0	11802788.0	11905513.0	11905513.0	12	-	ENST00000381340.3	35.0	26490342.0	26490342.0	26714885.0	26714885.0	Inferred Breakpoint	20033038
COSF681	ARFIP1	FHDC1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000353617.2(ARFIP1):r.1_369::ENST00000260008.3(FHDC1):r.1105_6480	4.0	+	ENST00000353617.2	2.0	153701112.0	153701112.0	153750878.0	153750878.0	4.0	+	ENST00000260008.3	8.0	153886057.0	153886057.0	153900848.0	153900848.0	Inferred Breakpoint	20033038
COSF685	INTS4	GAB2	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000534064.1(INTS4):r.1_281::ENST00000361507.4(GAB2):r.162_6092	11.0	-	ENST00000534064.1	2.0	77702154.0	77702154.0	77705724.0	77705724.0	11.0	-	ENST00000361507.4	2.0	77926343.0	77926343.0	77991947.0	77991947.0	Observed mRNA	20033038
COSF687	ACBD6	RRP15	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000367595.3(ACBD6):r.1_1261::ENST00000366932.3(RRP15):r.736_7771	1.0	-	ENST00000367595.3	5.0	180382501.0	180382501.0	180472089.0	180472089.0	1.0	+	ENST00000366932.3	5.0	218504290.0	218504290.0	218511325.0	218511325.0	Inferred Breakpoint	20033038
COSF689	PLXND1	TMCC1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000324093.4(PLXND1):r.1_2864::ENST00000393238.3(TMCC1):r.918_5992	3.0	-	ENST00000324093.4	12.0	129293179.0	129293179.0	129325661.0	129325661.0	3.0	-	ENST00000393238.3	4.0	129366635.0	129366635.0	129390107.0	129390107.0	Inferred Breakpoint	20033038
COSF691	JPT1	USH1G	breast	NS	carcinoma	NS	COSO28394862	ENST00000356033.4(JPT1):r.1_334::ENST00000319642.1(USH1G):r.1566_3561	17	-	ENST00000356033.4	1.0	73150437.0	73150437.0	73150770.0	73150770.0	17	-	ENST00000319642.1	3.0	72912176.0	72912176.0	72914171.0	72914171.0	Inferred Breakpoint	20033038
COSF693	NF1	ASIC2	breast	NS	carcinoma	NS	COSO28394862	ENST00000358273.4(NF1):r.1_4091::ENST00000225823.2(ASIC2):r.1582_3443	17	+	ENST00000358273.4	27.0	29421945.0	29421945.0	29560231.0	29560231.0	17	-	ENST00000225823.2	2.0	31340105.0	31340105.0	31439085.0	31439085.0	Inferred Breakpoint	20033038
COSF695	AGPAT5	MCPH1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000285518.6(AGPAT5):r.1_898::ENST00000344683.5(MCPH1):r.2529_3158	8.0	+	ENST00000285518.6	5.0	6565878.0	6565878.0	6599272.0	6599272.0	8.0	+	ENST00000344683.5	14.0	6500515.0	6500515.0	6501144.0	6501144.0	Observed mRNA	20033038
COSF697	CTAGE5	GEMIN2	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000280083.3(CTAGE5):r.1_2145::ENST00000308317.6(GEMIN2):r.887_1420	14.0	+	ENST00000280083.3	20.0	39736350.0	39736350.0	39796226.0	39796226.0	14.0	+	ENST00000308317.6	10.0	39605644.0	39605644.0	39606177.0	39606177.0	Inferred Breakpoint	20033038
COSF701	SUSD1	PTBP3	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000374270.3(SUSD1):r.1_1059::ENST00000374255.2(PTBP3):r.157_3413	9.0	-	ENST00000374270.3	6.0	114886537.0	114886537.0	114937688.0	114937688.0	9.0	-	ENST00000374255.2	2.0	114984525.0	114984525.0	115092754.0	115092754.0	Observed mRNA	20033038
COSF703	EIF3K	CYP39A1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000248342.4(EIF3K):r.1_671::ENST00000275016.2(CYP39A1):r.518_2176	19.0	+	ENST00000248342.4	6.0	39109737.0	39109737.0	39123318.0	39123318.0	6.0	-	ENST00000275016.2	3.0	46517541.0	46517541.0	46607405.0	46607405.0	Inferred Breakpoint	20033038
COSF705	IL6R	ATP8B2	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000368485.3(IL6R):r.1_1433::ENST00000368489.3(ATP8B2):r.131_5861	1.0	+	ENST00000368485.3	7.0	154377669.0	154377669.0	154420647.0	154420647.0	1.0	+	ENST00000368489.3	3.0	154302872.0	154302872.0	154323783.0	154323783.0	Observed mRNA	20033038
COSF707	RBM14	PACS1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000310137.4(RBM14):r.1_1941::ENST00000320580.4(PACS1):r.694_4392	11.0	+	ENST00000310137.4	2.0	66384053.0	66384053.0	66393149.0	66393149.0	11.0	+	ENST00000320580.4	5.0	65983590.0	65983590.0	66012218.0	66012218.0	Inferred Breakpoint	20033038
COSF709	FBXL18	RNF216	breast	NS	carcinoma	NS	COSO28394862	ENST00000382368.3(FBXL18):r.1_142::ENST00000389902.3(RNF216):r.2721_3293	7	-	ENST00000382368.3	1.0	5553288.0	5553288.0	5553429.0	5553429.0	7	-	ENST00000389902.3	17.0	5662238.0	5662238.0	5662810.0	5662810.0	Observed mRNA	20033038
COSF711	ATG4C	FBXO38	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000371120.3(ATG4C):r.1_1368::ENST00000340253.5(FBXO38):r.1433_4424	1.0	+	ENST00000371120.3	10.0	63249806.0	63249806.0	63307218.0	63307218.0	5.0	+	ENST00000340253.5	11.0	147795491.0	147795491.0	147822399.0	147822399.0	Inferred Breakpoint	20033038
COSF713	GMDS	PDE8B	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000380815.4(GMDS):r.1_372::ENST00000264917.5(PDE8B):r.2594_5956	6.0	-	ENST00000380815.4	1.0	2245555.0	2245555.0	2245926.0	2245926.0	5.0	+	ENST00000264917.5	22.0	76722270.0	76722270.0	76725632.0	76725632.0	Observed mRNA	20033038
COSF716	SLC22A1	CUTA	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000366963.4(SLC22A1):r.1_986::ENST00000440279.3(CUTA):r.548_822	6.0	+	ENST00000366963.4	4.0	160542821.0	160542821.0	160555157.0	160555157.0	6.0	-	ENST00000440279.3	4.0	33384329.0	33384329.0	33384746.0	33384746.0	Observed mRNA	20033038
COSF718	TECTA	TBCEL	breast	NS	carcinoma	NS	COSO28394862	ENST00000392793.1(TECTA):r.1_1474::ENST00000529397.1(TBCEL):r.1057_1375	11	+	ENST00000392793.1	7.0	120971882.0	120971882.0	120989427.0	120989427.0	11	+	ENST00000529397.1	8.0	120957487.0	120957487.0	120957805.0	120957805.0	Observed mRNA	20033038
COSF720	FGFR1	ZNF703	breast	NS	carcinoma	NS	COSO28394862	ENST00000447712.2(FGFR1):r.1_2919::ENST00000331569.4(ZNF703):r.473_3347	8	-	ENST00000447712.2	14.0	38272297.0	38272297.0	38326352.0	38326352.0	8	+	ENST00000331569.4	2.0	37554663.0	37554663.0	37557537.0	37557537.0	Inferred Breakpoint	20033038
COSF722	SSH2	SUZ12	breast	NS	carcinoma	NS	COSO28394862	ENST00000269033.3(SSH2):r.1_259::ENST00000322652.5(SUZ12):r.1054_4491	17	-	ENST00000269033.3	2.0	28120912.0	28120912.0	28257170.0	28257170.0	17	+	ENST00000322652.5	8.0	30303541.0	30303541.0	30328064.0	30328064.0	Inferred Breakpoint	20033038
COSF724	BBS9	PKD1L1	breast	NS	carcinoma	NS	COSO28394862	ENST00000242067.6(BBS9):r.1_1537::ENST00000289672.2(PKD1L1):r.3494_9092	7	+	ENST00000242067.6	9.0	33169144.0	33169144.0	33313568.0	33313568.0	7	-	ENST00000289672.2	21.0	47814250.0	47814250.0	47920403.0	47920403.0	Observed mRNA	20033038
COSF726	NTN1	ACLY	breast	NS	carcinoma	NS	COSO28394862	ENST00000173229.2(NTN1):r.1_1518::ENST00000352035.2(ACLY):r.1197_4339	17	+	ENST00000173229.2	5.0	8924859.0	8924859.0	9086286.0	9086286.0	17	-	ENST00000352035.2	11.0	40023161.0	40023161.0	40058066.0	40058066.0	Observed mRNA	20033038
COSF728	PLA2R1	RBMS1	breast	NS	carcinoma	ductal carcinoma	COSO28395278	ENST00000283243.7(PLA2R1):r.1_2802::ENST00000392753.3(RBMS1):r.558_1702	2.0	-	ENST00000283243.7	17.0	160832579.0	160832579.0	160919121.0	160919121.0	2.0	-	ENST00000392753.3	5.0	161130996.0	161130996.0	161159998.0	161159998.0	Inferred Breakpoint	20033038
COSF752	BCR	JAK2	blood-lymph	NS	haematopoietic neoplasm	chronic myeloid leukaemia	COSO27985052	ENST00000305877.8(BCR):r.1_2030::ENST00000381652.3(JAK2):r.2929_5285	22	+	ENST00000305877.8	1.0	23522397.0	23522397.0	23524426.0	23524426.0	9	+	ENST00000381652.3	19.0	5081725.0	5081725.0	5128183.0	5128183.0	Inferred Breakpoint	16001431
COSF754	TCF12	NR4A3	bone	extraskeletal	chondrosarcoma	myxoid	COSO52146410	ENST00000438423.2(TCF12):r.1_621::ENST00000395097.2(NR4A3):r.728_3794	15	+	ENST00000438423.2	5.0	57210821.0	57210821.0	57384089.0	57384089.0	9	+	ENST00000395097.2	3.0	102590323.0	102590323.0	102627333.0	102627333.0	Inferred Breakpoint	11156374
COSF799	CLTC	TFE3	kidney	NS	carcinoma	TFE3-rearranged renal cell carcinoma	COSO296411564	ENST00000269122.3(CLTC):r.1_3070::ENST00000315869.7(TFE3):r.1146_3415	17	+	ENST00000269122.3	17.0	57697219.0	57697219.0	57754549.0	57754549.0	X	-	ENST00000315869.7	6.0	48886242.0	48886242.0	48891766.0	48891766.0	Inferred Breakpoint	12917640
COSF803	SFPQ	TFE3	kidney	NS	carcinoma	TFE3-rearranged renal cell carcinoma	COSO296411982	ENST00000357214.5(SFPQ):r.1_2085::ENST00000315869.7(TFE3):r.1041_3415	1	-	ENST00000357214.5	9.0	35652602.0	35652602.0	35658749.0	35658749.0	X	-	ENST00000315869.7	5.0	48886242.0	48886242.0	48895639.0	48895639.0	Inferred Breakpoint	19809274
COSF805	PRCC	TFE3	kidney	NS	carcinoma	TFE3-rearranged renal cell carcinoma	COSO296411564	ENST00000271526.4(PRCC):r.1_740::ENST00000315869.7(TFE3):r.795_3415	1	+	ENST00000271526.4	1.0	156737292.0	156737292.0	156738031.0	156738031.0	X	-	ENST00000315869.7	4.0	48886242.0	48886242.0	48895967.0	48895967.0	Observed mRNA	8986805
COSF826	ESRP1	RAF1	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000358397.5(ESRP1):r.1_1953::ENST00000251849.4(RAF1):r.1022_3300	8	+	ENST00000358397.5	13.0	95653402.0	95653402.0	95690599.0	95690599.0	3	-	ENST00000251849.4	6.0	12625100.0	12625100.0	12647798.0	12647798.0	Inferred Breakpoint	20526349
COSF865	NONO	TFE3	kidney	NS	carcinoma	TFE3-rearranged renal cell carcinoma	COSO296411564	ENST00000276079.8(NONO):r.1_1336::ENST00000315869.7(TFE3):r.1146_3415	X	+	ENST00000276079.8	9.0	70503433.0	70503433.0	70517788.0	70517788.0	X	-	ENST00000315869.7	6.0	48886242.0	48886242.0	48891766.0	48891766.0	Inferred Breakpoint	9393982
COSF871	SLC45A3	BRAF	prostate	NS	carcinoma	adenocarcinoma	COSO32054826	ENST00000367145.3(SLC45A3):r.1_66::ENST00000288602.6(BRAF):r.1042_2480	1	-	ENST00000367145.3	1.0	205649522.0	205649522.0	205649587.0	205649587.0	7	-	ENST00000288602.6	8.0	140434279.0	140434279.0	140494267.0	140494267.0	Observed mRNA	20526349
COSF878	MYB	NFIB	breast	NS	carcinoma	adenoid cystic carcinoma	COSO32226015	ENST00000341911.5(MYB):r.1_2368::ENST00000397581.2(NFIB):r.2254_3318	6	+	ENST00000341911.5	15.0	135502453.0	135502453.0	135524462.0	135524462.0	9	-	ENST00000397581.2	9.0	14087599.0	14087599.0	14116345.0	14116345.0	Observed mRNA	19841262
COSF962	HMGA2	LPP	bone	extraskeletal	other	chondroma	COSO31366169	ENST00000403681.2(HMGA2):r.1_1389::ENST00000312675.4(LPP):r.1657_18278	12	+	ENST00000403681.2	3.0	66217911.0	66217911.0	66232349.0	66232349.0	3	+	ENST00000312675.4	9.0	188583988.0	188583988.0	188608460.0	188608460.0	Observed mRNA	18383898
